Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
Ruan, Yongsheng, Kim, Hye Na, Ogana, Heather A, Wan, Zesheng, Hurwitz, Samantha, Nichols, Cydney, Abdel-Azim, Nour, Coba, Ariana, Seo, Seyoung, Loh, Yong-Hwee Eddie, Gang, Eun Ji, Abdel-Azim, Hisham, Hsieh, Chih-Lin, Lieber, Michael R, Parekh, Chintan, Pal, Dhananjaya, Bhojwani, Deepa, Durden, Donald L, Kim, Yong-Mi
Published in Frontiers in oncology (01.12.2021)
Published in Frontiers in oncology (01.12.2021)
Get full text
Journal Article
Dual Targeting of PI3Kdelta and BRD4 Sensitizes Acute Lymphoblastic Leukemia to Chemotherapy
Kim, Hye Na, Nichols, Cydney, Jiang, Enzi Ji, Abdel-Azim, Nour, Coba, Ariana, Durden, DOnald L., Kim, Yong-Mi
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article